New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
10:13 EDTDGXQuest Diagnostics gaps down, spikes lower, after earnings
The stock was last down over 6.5% which is off the lows of the session. The company reported earnings of $1.01 per share versus consensus of $1.02 for its Q4. It is guidance which is taking the shares down, which was reduced to a range of $4.35 to $4.55 for its fiscal year 2013 versus consensus of $4.81. At the current price of $57.66, support is at $57.11. a recent pivot low on the daily chart. Resistance is at $58, today's opening price.
News For DGX From The Last 14 Days
Check below for free stories on DGX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
07:08 EDTDGXLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use